Van Cleef Asset Management’s Merck MRK Stock Holding History

Van Cleef Asset Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.29M	Sell	19,008 -50	-0.3%	-$5.77K	0.25%	42
2025 Q4	$2.01M	Hold	19,058	–	–	0.2%	45
2025 Q3	$1.6M	Sell	19,058 -300	-2%	-$24.7K	0.16%	49
2025 Q2	$1.53M	Hold	19,358	–	–	0.17%	48
2025 Q1	$1.74M	Sell	19,358 -1,650	-8%	-$154K	0.2%	47
2024 Q4	$2.09M	Sell	21,008 -60	-0.3%	-$6.19K	0.23%	47
2024 Q3	$2.39M	Buy	21,068 +12	+0.1%	+$1.43K	0.27%	46
2024 Q2	$2.61M	Sell	21,056 -150	-0.7%	-$19.3K	0.33%	40
2024 Q1	$2.8M	Sell	21,206 -199	-0.9%	-$24.5K	0.35%	39
2023 Q4	$2.33M	Sell	21,405 -202	-0.9%	-$21K	0.33%	43
2023 Q3	$2.22M	Sell	21,607 -148	-0.7%	-$16K	0.35%	41
2023 Q2	$2.51M	Buy	21,755 +205	+1%	+$23.3K	0.39%	41
2023 Q1	$2.29M	Sell	21,550 -149	-0.7%	-$16.1K	0.36%	41
2022 Q4	$2.41M	Sell	21,699 -201	-0.9%	-$20.5K	0.4%	42
2022 Q3	$1.89M	Sell	21,900 -150	-0.7%	-$13.4K	0.36%	43
2022 Q2	$2.01M	Sell	22,050 -224	-1%	-$19.9K	0.34%	43
2022 Q1	$1.83M	Hold	22,274	–	–	0.26%	49
2021 Q4	$1.71M	Buy	22,274 +40	+0.2%	+$3.19K	0.24%	48
2021 Q3	$1.67M	Hold	22,234	–	–	0.25%	47
2021 Q2	$1.73M	Sell	22,234 -1,067	-5%	-$79.4K	0.26%	47
2021 Q1	$1.71M	Hold	23,301	–	–	0.27%	46
2020 Q4	$1.82M	Hold	23,301	–	–	0.3%	44
2020 Q3	$1.84M	Hold	23,301	–	–	0.34%	39
2020 Q2	$1.72M	Sell	23,301 -9,223	-28%	-$694K	0.35%	39
2020 Q1	$2.39M	Sell	32,524 -314	-1%	-$24.7K	0.59%	30
2019 Q4	$2.85M	Hold	32,838	–	–	0.58%	34
2019 Q3	$2.64M	Sell	32,838 -197	-0.6%	-$15.8K	0.58%	34
2019 Q2	$2.64M	Hold	33,035	–	–	0.58%	32
2019 Q1	$2.62M	Buy	33,035 +891	+3%	+$66.6K	0.61%	30
2018 Q4	$2.34M	Sell	32,144 -472	-1%	-$33.3K	0.63%	31
2018 Q3	$2.21M	Sell	32,616 -247	-0.8%	-$15.7K	0.49%	35
2018 Q2	$1.9M	Buy	32,863 +1	+0%	+$56	0.46%	38
2018 Q1	$1.71M	Sell	32,862 -1,152	-3%	-$62.2K	0.42%	41
2017 Q4	$1.83M	Buy	34,014 +9,551	+39%	+$529K	0.45%	41
2017 Q3	$1.5M	Buy	24,463 +1	+0%	+$61	0.41%	44
2017 Q2	$1.5M	Sell	24,462 -838	-3%	-$51K	0.44%	43
2017 Q1	$1.53M	Hold	25,300	–	–	0.47%	42
2016 Q4	$1.42M	Buy	25,300 +33	+0.1%	+$1.93K	0.45%	42
2016 Q3	$1.5M	Sell	25,267 -157	-0.6%	-$9.18K	0.5%	39
2016 Q2	$1.4M	Buy	25,424 +1	+0%	+$53	0.48%	41
2016 Q1	$1.28M	Sell	25,423 -79	-0.3%	-$3.87K	0.45%	41
2015 Q4	$1.28M	Sell	25,502 -444	-2%	-$22.4K	0.47%	43
2015 Q3	$1.22M	Buy	25,946 +471	+2%	+$25K	0.48%	43
2015 Q2	$1.38M	Sell	25,475 -419	-2%	-$23.5K	0.52%	40
2015 Q1	$1.42M	Sell	25,894 -419	-2%	-$23.7K	0.53%	41
2014 Q4	$1.43M	Buy	26,313 +11,109	+73%	+$619K	0.53%	41
2014 Q3	$860K	Hold	15,204	–	–	0.35%	47
2014 Q2	$839K	Buy	15,204 +3,144	+26%	+$172K	0.35%	45
2014 Q1	$653K	Hold	12,060	–	–	0.29%	49
2013 Q4	$576K	Hold	12,060	–	–	0.25%	53
2013 Q3	$548K	Sell	12,060 -1,468	-11%	-$67K	0.27%	54
2013 Q2	$600K	Buy	+13,528	New	+$604K	0.32%	53

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Van Cleef Asset Management's MRK Position: Q1 2026 in Review

Van Cleef Asset Management reduced its Merck (MRK) stake by 0.26% in Q1 2026, selling an estimated $5.77K and leaving 19,008 shares worth $2.29M. The position accounts for 0.25% of the portfolio, ranked #42.

Van Cleef Asset Management first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.85M in Q4 2019. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

Van Cleef Asset Management held 19,008 shares of Merck worth $2.29M as of Q1 2026.
Van Cleef Asset Management sold 50 Merck shares in Q1 2026, an estimated $5.77K.
Merck made up 0.25% of Van Cleef Asset Management's portfolio in Q1 2026, its #42 holding.
Van Cleef Asset Management first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
Van Cleef Asset Management's Merck position peaked at $2.85M in Q4 2019.
3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Van Cleef Asset Management's 13F filing for Q1 2026, filed 1 May 2026.